Respiratory syncytial virus is common but it can be dangerous for some infants and young kids. Here's everything parents need ...

The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...

The FDA has given the green light to expand the use of Moderna's vaccine for the treatment of RSV, the virus that causes ...

The "magic rods" are surgically implanted and can be slowly lengthened with internal and external magnets. It is a less invasive treatment than traditional methods involving body casts and surgeries.

The CDC's Advisory Committee on Immunization Practices (ACIP) has issued new vaccine recommendations affecting RSV and flu ...

A major UK-led clinical trial has found that a treatment commonly used to help premature babies breathe offers no benefit for ...

In the U.S., respiratory syncytial virus (RSV) is responsible for up to 160,000 hospitalizations and 10,000 deaths annually among adults aged 65 and older.

Chicago, June 09, 2025 (GLOBE NEWSWIRE) -- The global respiratory syncytial virus treatment market valued at USD 2,387.2 million in 2024 and is projected to reach USD 8,332.5 million by 2033 ...

Treatment for RSV conjunctivitis, which is conjunctivitis caused by the respiratory syncytial virus (RSV), usually involves eye drops, cold compresses, and resting to clear the infection.

The analysis found that among newborns (0–2 months), RSV hospitalizations fell 52 percent in RSV-NET and 45 percent in NVSN compared with the rates from the 2018–2020 period.

Key Takeaways An antibody treatment effectively protects babies against RSV infectionThe treatment reduced the risk of hospitalization by 83%U.S. babies enjoyed better protection because treatment ...